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Article Information  ABSTRACT 
Received: 15th March 2017  A simple, sensitive and accurate stability indicating HPTLC method has been developed and 
validated for estimation of Dextromethorphan hydrobromide in bulk and pharmaceutical dosage 
form. The drug was spotted on precoated silica gel 60 F254 aluminum plates using Toluene: 
Methanol: Triethylamine (8.5:1:0.5 v/v/v) as mobile phase. The retention factor (Rf) was found 
to be 0.60±1.92. The detection of band was carried at 225 nm. The drug was subjected to 
different stress conditions like acid, base, neutral hydrolysis, oxidation, thermal degradation and 
photolysis. The method was successfully validated according to ICH guidelines Q2 (R1). The 
data of linear regression analysis indicated a good linear relationship over the concentration 
range of 2000-20000 ng/band with correlation coefficient 0.991. The method found to be 
accurate as results of the recovery studies are close to 100 %. The developed method was found 
to be simple, sensitive, selective, accurate and repeatable for analysis of and can be adopted for 
routine analysis of drug in bulk and pharmaceutical dosage form.  
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INTRODUCTION 
Dextromethorphan hydrobromide chemically, it is morphinan, 
3-methoxy-17-meth (9, 13, 14)-, hydrobromide. It is antitussive 
(cough suppressant) drug used for the pain relief and in 
psychological conditions. It acts on cough centre to elevate the 
threshold for coughing [1]. Literature survey reveals methods 
reported viz simple HPLC [2]-[4] and bioanalytical HPLC 
method [5] for estimation of Dextromethorphan hydrobromide.  
 
To the best of our knowledge no stability indicating HPTLC 
method has been reported for estimation of Dextromethorphan 
hydrobromide. The present work describes a simple stability 
indicating HPTLC method for the determination of 
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Dextromethorphan hydrobromide in bulk and pharmaceutical 
dosage form (DMR-20) according to the International 
conference on harmonization (ICH) guidelines [6][7]. 
 
MATERIALS AND METHODS 
Reagents and chemicals  
Authentic sample of Dextromethorphan hydrobromide was 
obtained from Medley Pharmaceuticals Limited, Mumbai. The 
formulation DMR – 20 labeled to contain Dextromethorphan 
hydrobromide 20 mg was procured form local market. 
Methanol (AR grade), Toluene (AR grade) were purchased 
from S. D. Fine Chemical Laboratories, Mumbai. Hydrochloric 
acid (HCl), hydrogen peroxide (H2O2) and sodium hydroxide 
(NaOH), Triethylamine were purchased from  LOBA CHEMIE 
PVT. LTD., Mumbai. 
 
Chromatographic condition: 
Chromatographic separation of drug was performed on 
aluminum plates precoated with silica gel 60 F254, (10 cm × 10 
cm with 250 µm layer thickness). Sample was applied on the 
plate as a band of 4 mm width using Camag 100 μl sample 
syringe (Hamilton, Switzerland) with a Linomat 5 applicator 
 
(Camag, Switzerland). The mobile phase was composed of 
Toluene: Methanol: Triethylamine (8.5:1:0.5 v/v/v). 10 cm × 
10 cm CAMAG twin trough glass chamber was used for linear 
ascending development of TLC plate under 15 min saturation 
conditions and 10 ml of mobile phase was used per run, 
migration distance was 80 mm. Densitometric scanning was 
performed using Camag TLC scanner at 225 nm, operated by 
win CATS software, slit dimensions were 3.00 x 0.45 mm and 
Deuterium lamp was used as a radiation source. 
 
Selection of Detection Wavelength 
From the standard stock solution (1000 µg/ml) further dilutions 
were made using methanol and scanned over the range of 200 - 
400 nm and the spectra was obtained. It was observed that the 
drug showed considerable absorbance at 225 nm. 
Representative UV spectrum of Dextromethorphan 
hydrobromide is shown in Figure 1. 
 
Preparation of Standard stock solution 
Standard stock solution of drug was prepared by dissolving 10 
mg of the drug in 10 ml of methanol to get concentration of 
1000 µg/ml. From the standard stock solution, working 
standard solution was prepared containing 100 µg/ml of 
Dextromethorphan hydrobromide. 10 µl of the resultant 
solution was applied on TLC plate to get concentration of 1000 
ng/band.Representative densitogram of Dextromethorphan 
hydrobromide (1000 ng/band) is shown in Figure 2. 
 
Preparation of sample solution 
A tablet containing 20 mg of Dextromethorphan hydrobromide 
(DMR-20) was weighed and powdered. Powder equivalent to 
10 mg of drug was transferred to 10 ml volumetric flask and 
volume was made up with methanol to get concentration (1000 
µg/ml) and was sonicated for 10 min. Solution was filtered,  4 
µl of the resultant solution was applied on TLC plate to get 
concentration of 4000 ng/band. 
 
Figure 1: Representative UV spectrum of Dextromethorphan 
Hydrobromide (10 ug/ml) 
 
Stress degradation studies of bulk drug 
Stability studies were carried out to provide evidence on how 
the quality of drug varies under the influence of a variety of 
environmental conditions like acidic, alkaline, hydrolysis, and 
oxidation. Dry heat and photolytic degradation were carried out 
in the solid state. All studies are carried out at concentration 
level of 16,000 ng/band. 
 
Alkaline hydrolysis 
To 1 ml of stock solution of Dextromethorphan hydrobromide 
(10,000 µg/ml) , 1 ml of 1 N NaOH was added. The above 
solution was kept for 4 hours at room temperature. The volume 
was made up to 10 ml with methanol. 16 µl of the resultant 
solution was then applied at TLC plate and densitogram was 
developed. Average 96.01 % of Dextromethorphan 
hydrobromide was recovered with one peak of degradation. 
Representative densitogram is shown in Figure 3. 
 
Acid hydrolysis 
To 1 ml of stock solution of Dextromethorphan hydrobromide 
(10,000 µg/ml), 1ml of 1 N HCl was added. The above solution 
was kept for 4 hour at room temperature. The volume was 
0
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made upto 10 ml with methanol. 16 µl of the resultant solution 
was then applied at TLC plate and densitogram was developed. 
66.34% Dextromethorphan hydrobromide was recovered with 
no peak of degradant.Representative densitogram  is shown in 
Figure 4. 
 
Neutral Hydrolysis 
To 1 ml of stock solution of Dextromethorphan hydrobromide 
(10,000 µg/ml), 1ml of distilled water was added. The above 
solution was kept for 4 hours at room temperature. The volume 
was made upto 10 ml with methanol. 16 µl of the resultant 
solution was then applied at TLC plate and densitogram was 
developed. 94.51% of  Dextromethorphan hydrobromide was 
recovered with no peak of degradant. Representative 
densitogram is shown in Figure 5.  
 
Degradation under oxidative condition  
To 1 ml of stock solution of Dextromethorphan hydrobromide 
(10,000µg/ml), 1ml of 6% H2O2 was added. The above solution 
was kept for 4 hour at room temperature. The volume was 
made upto 10 ml with methanol.  16 µl of the resultant solution 
was then applied at TLC plate and densitogram was developed. 
Average 86.53% of Dextromethorphan hydrobromide was 
recovered with no peak of degradant. Representative 
densitogram is shown in Figure 6. 
 
 
Figure 2: Representative Densitogram of Dextromethorphan Hydrobromide (1000 ng/band) 
 
 
Figure 3: Representative Densitogram of (A) base induced degradation of Dextromethorphan hydrobromide 16,000 ng/band 
showing degradant (B) Overlain spectra of Dextromethorphan hydrobromide and its alkali degradant 
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Figure 4: Representative Densitogram of Dextromethorphan hydrobromide after acid degradation 
 
Figure 5: Representative Densitogram of Dextromethorphan hydrobromide after  Neutral degradation 
 
Figure 6: Representative Densitogram of Dextromethorphan hydrobromide after Oxidation degradation 
 
Figure 7: Representative Densitogram of Dextromethorphan hydrobromide after Thermal degradation 
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Figure 8: Representative Densitogram of Dextromethorphan hydrobromide after Photolytic degradation 
Degradation under dry heat 
Dry heat studies were performed by keeping drug sample in 
oven (800 C) for a period of 4 hours. Sample was withdrawn, 
dissolved in methanol and diluted to get 1000 μg/ml. 16 µl of 
the resultant solution was then applied at TLC plate and 
densitogram was developed. Average of 91.91% 
dextromethorphan hydrobromide was recovered with no peak 
of degradant. Representative densitogram is shown in Figure 7. 
 
Photo-degradation studies 
The photo degradation study of the drug was studied by 
exposing the drug to UV light providing illumination of NLT 
200 watt hr/m2. After exposure, sample was withdrawn, 
dissolved in methanol and diluted to get 1000 μg/ml. 16 µl of 
the resultant solution was then applied at TLC plate and 
densitogram was developed. Average 47.45% of 
dextromethorphan hydrobromide was recovered with no peak 
of degradant. Representative densitogram is shown in Figure 8. 
 
VALIDATION OF ANALYTICAL METHOD 
Specificity 
The specificity of the method was ascertained by peak purity 
profile studies. The peak purity values were found to be more 
than 0.998, indicating the no interference of any other peak of 
degradation product, impurity or matrix.  
 
Figure 9: Calibration curve of Dextromethorphan 
hydrobromide 
Linearity 
From the standard stock solution (1000 µg/ml) of 
Dextromethorphan hydrobromide, Six replicates per 
concentration were spotted. The linearity (relationship between 
peak area and concentration) was determined by analyzing six 
concentrations over the concentration range of 2000-20,000 
ng/band for Dextromethorphan hydrobromide. The peak areas 
were plotted against the corresponding concentrations to obtain 
the calibration curve as shown in figure 8. The results found to 
be linear with regression equation of y=0.8592x+2599 with R² 
= 0.991. 
Precision 
The precision of the method was demonstrated by intra-day and 
inter-day variation studies. In the intra-day studies 3 replicates 
of 3 concentrations were analyzed on the same day and 
percentage RSD were calculated. For the inter day variation 
studies, 3 replicates of 3 concentrations were analyzed on 3 
consecutive days and percentage RSD were calculated. For 
intraday precision and inter-day precision results obtained are 
shown in Table 1. 
Limit of Detection (LOD) and Limit of Quantitation (LOQ) 
From the linearity data the limit of detection and quantitation 
was calculated, using the formula LOD = 3.3 σ/ S and LOQ = 
10 σ/ S where σ is standard deviation of the y intercept of 
linearity equation and S is slope of the calibration curve of the 
analyte. The LOD and LOQ were found to be 357.31ng/ band 
and 1082.76 ng/band, respectively. 
Assay 
DMR – 20 tablet formulation analysis was carried out as 
mentioned under section preparation of sample solution. 
Procedure was repeated for six times. Sample solution was 
applied and area was recorded. Basic concentration of sample 
chosen was 4000 ng/band from tablet solution. Concentration 
and % recovery was determined from linear equation. Assay 
results obtained are shown in Table 2. 
y = 0.859x + 2599
R² = 0.991
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Table 1: Intraday and interday variation studies data for 
Dextromethorphan hydrobromide 
Concent
ration 
(μg/ml) 
Intra-day Precision Inter-day Precision 
Average 
area 
% Reco-
-very 
% 
RSD 
Average 
area 
%Reco-
-very 
% 
RSD 
4000 
6065 100.85  
1.15 
 
6051.2 100.06  
0.45 
 
6087.2 101.50 6077.5 100.83 
6010.3 99.26 6050.2 100.03 
8000 
9490.3 100.26  
0.40 
 
9440.8 99.309  
0.40 
 
9486.7 100.21 9465.6 99.670 
9440.8 99.54 9411 98.876 
12,000 
13076.4 101.62 
 
0.70 13009.9 100.80 
0.71 
 
Table 2: Assay of marketed formulation 
 
Drug 
 
Peak 
Area 
Amount 
Recovered 
(μg/ml) 
% 
Recovery 
± %RSD 
Dextromethor
phan 
hydrobromide 
5988.7 3945.18 98.62 
1.40 
 
5956.2 3907.35 97.68 
6050.5 4017.10 100.42 
6038.3 4002.91 100.07 
6051.5 4018.27 100.45 
6089.5 4062.52 101.56 
 
Table 3: Accuracy Studies of Dextromethorphan hydrobromide 
 
 
Level 
Amount 
of 
sample 
taken 
(ng/band) 
Amount 
standard 
spiked 
(ng/band) 
 
Area 
% 
Recovery 
 
±% 
RSD 
50% 4000 2000 
7687.3 98.70 
0.60 7635.5 97.69 
7689.3 98.74 
100% 4000 4000 
9427.4 99.34 
1.79 9277.6 97.16 
9520.3 100.69 
150% 4000 6000 
11130.7 99.29 
0.92 11164.1 99.68 
11282.6 101.06 
 
Accuracy  
To check accuracy of the method, recovery studies were carried 
by spiking the standard drug to the tablet solution, at three 
different levels 50, 100 and 150 %.Basic concentration of 
sample chosen was 4000 ng/band. % recovery was determined 
from linearity equation. The results obtained are shown in 
Table 3. 
 
Robustness 
Robustness of the method was determined by carrying out the 
analysis under conditions during which Detection wavelength, 
Time was changed from spotting to development and 
development to scanning and the effect on the area was noted. 
It was found that method is robust. 
 
RESULT AND DISCUSSION 
Method development: It was observed that the drug showed 
considerable absorbance at 225 nm. After few trials, 
Toluene:Methanol:Triethylamine (8.5:1:0.5 v/v/v) was chosen 
as mobile phase with saturation time 15 min, which gave good 
resolution and acceptable peak parameters.  The densitometric 
analysis of drug was carried out at 225 nm.  
 
The Rf value was found to be 0.60 ± 1.92. The results indicated 
the suitability of the method to study the stability of 
Dextromethorphan hydrobromide under various forced 
degradation conditions like acidic, basic, hydrolysis, oxidation, 
dry heat and photolysis. The method was found to be accurate, 
specific, Precise and robust. Summary of validation parameter 
and stability study was given in following table. 
 
Table 4: Summary of validation parameters 
S. No. Parameter Dextromethorphan HBr 
1 Linearity Y = 0.8592x + 2599 
2 Range 2,000 – 20,000 ng / band 
 
3 
Precision %RSD 
Intraday 0.40 – 1.15 
Interday 0.40 – 0.71 
4 Assay 99.8 % 
 
 
5 
Accuracy % Recovery 
50% 0.60 
100% 1.79 
150% 0.92 
6 LOD 357.31 ng / band 
7 LOQ 1082.76 ng / band 
8 Specificity Specific 
9 Robustness Robust 
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Table 4: Summary of forced degradation study 
Stress condition/Duration % Assay of 
active 
substance 
Rf values of 
degraded 
products 
Acidic/ 1 N HCl/ at room 
temperature 4 hours 
66.34% 
 
- 
 
Alkaline/ 1 N NaOH / at 
room temperature 4 hours 
96.01% 
 
0.23 
 
Oxidative/ 6 % H2O2 / at 
room temperature 4 hours 
86.53% 
 
- 
 
Neutral /  H2O / at room 
temperature 4 hrs 
94.51% - 
 
Dry heat /  80ºC/  4 hours 91.91% - 
UV/200 watt hours/square 
meter / for 24 hours 
47.45% - 
 
CONCLUSION 
A simple, precise, accurate, reproducible and stability-
indicating HPTLC method without interference from the 
excipients or from degradation products has been developed 
and validated for the determination of Dextromethorphan 
hydrobromide as bulk drug and in tablet dosage form. The 
developed method can be used for quantitative analysis of 
Dextromethorphan hydrobromide in pharmaceutical dosage 
form. The method was developed by using easily available and 
cheap solvents for analysis of drug hence can be considered as 
economic.  
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